Joseph Ciaffoni Collegium Pharmaceutical, Inc (COLL) insider trading activity

Joseph Ciaffoni is President and CEO of COLLEGIUM PHARMACEUTICAL, INC. Currently has a direct ownership of 444,867 shares of COLL, which is worth approximately $12.9 Million. The most recent transaction as insider was on Feb 12, 2024, when has been sold 128,867 shares (Common Stock) at a price of $33.7 per share, resulting in proceeds of $4,342,817. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 445K

0% 3M change

61.77% 12M change

Total Value Held $12.9 Million

Joseph Ciaffoni Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 12 2024	SELL Payment of exercise price or tax liability	$4,342,817 $33.7 p/Share	128,867 Reduced 22.46%	444,867 Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	-	298,734 Added 34.24%	573,734 Common Stock
Dec 21 2023	SELL Open market or private sale	$132,365 $30.38 p/Share	4,357 Reduced 1.56%	275,000 Common Stock
Dec 21 2023	BUY Exercise of conversion of derivative security	$92,978 $21.34 p/Share	4,357 Added 1.54%	279,357 Common Stock
Dec 20 2023	SELL Open market or private sale	$804,201 $30.4 p/Share	26,454 Reduced 8.78%	275,000 Common Stock
Dec 20 2023	BUY Exercise of conversion of derivative security	$564,528 $21.34 p/Share	26,454 Added 8.07%	301,454 Common Stock
Dec 19 2023	SELL Open market or private sale	$435,915 $30.03 p/Share	14,516 Reduced 5.01%	275,000 Common Stock
Dec 19 2023	BUY Exercise of conversion of derivative security	$309,771 $21.34 p/Share	14,516 Added 4.77%	289,516 Common Stock
Dec 18 2023	SELL Open market or private sale	$835,051 $30.04 p/Share	27,798 Reduced 9.18%	275,000 Common Stock
Dec 18 2023	BUY Exercise of conversion of derivative security	$593,209 $21.34 p/Share	27,798 Added 8.41%	302,798 Common Stock
Jun 02 2023	SELL Open market or private sale	$685,482 $21.92 p/Share	31,272 Reduced 10.21%	275,000 Common Stock
Jun 01 2023	SELL Open market or private sale	$690,798 $22.09 p/Share	31,272 Reduced 9.26%	306,272 Common Stock
May 31 2023	SELL Open market or private sale	$683,918 $21.87 p/Share	31,272 Reduced 8.48%	337,544 Common Stock
May 30 2023	SELL Open market or private sale	$684,834 $21.9 p/Share	31,271 Reduced 7.82%	368,816 Common Stock
Feb 13 2023	SELL Open market or private sale	$302,400 $26.88 p/Share	11,250 Reduced 2.73%	400,087 Common Stock
Feb 13 2023	BUY Exercise of conversion of derivative security	$178,875 $15.9 p/Share	11,250 Added 2.66%	411,337 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$2,778,174 $26.75 p/Share	103,857 Reduced 20.61%	400,087 Common Stock
Feb 10 2023	BUY Grant, award, or other acquisition	-	255,194 Added 33.62%	503,944 Common Stock
Dec 27 2022	SELL Open market or private sale	$52,719 $23.92 p/Share	2,204 Reduced 0.88%	248,750 Common Stock
Dec 23 2022	SELL Open market or private sale	$3,381 $23.0 p/Share	147 Reduced 0.06%	250,954 Common Stock
Dec 22 2022	SELL Open market or private sale	$2,530 $23.0 p/Share	110 Reduced 0.04%	251,101 Common Stock
Dec 21 2022	SELL Open market or private sale	$169,465 $23.11 p/Share	7,333 Reduced 2.84%	251,211 Common Stock
Dec 20 2022	SELL Open market or private sale	$216,281 $23.07 p/Share	9,375 Reduced 3.5%	258,544 Common Stock
Dec 19 2022	SELL Open market or private sale	$26,093 $23.01 p/Share	1,134 Reduced 0.42%	267,919 Common Stock
Dec 02 2022	SELL Open market or private sale	$1,255,008 $23.07 p/Share	54,400 Reduced 16.82%	269,053 Common Stock

Joseph Ciaffoni

President and CEO

Stoughton, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COLL shares.

Notify only if

Value

Insider Trading

Get notified when an Collegium Pharmaceutical, Inc insider buys or sells COLL shares.

Notify only if

Operation

Value

Type

News

Receive news related to COLLEGIUM PHARMACEUTICAL, INC

Track Activities on COLL

Account